No Data
H.C. Wainwright Maintains Oramed Pharmaceuticals(ORMP.US) With Hold Rating
Oramed Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Oramed Pharmaceuticals (ORMP): Shareholder Letter Spurs Bullish Trend
Express News | Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech
Express News | Oramed Pharmaceuticals And Hefei Tianhui Biotech Finalize Joint Venture; JV To Receive Capital Infusion With HTIT Committing $70M In Cash And Oramed Investing $25M In Cash and Stock
Express News | Oramed Pharmaceuticals: Htit Committing $70 Mln in Cash, Co Investing $25 Mln in Cash & Stock in Jv